HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?

Lambein, Kathleen; Libbrecht, Louis; Galant, Christine; Van Bockstal, Mieke R

HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?

Lambein, Kathleen; Libbrecht, Louis; Galant, Christine; Van Bockstal, Mieke R.

Afiliação

Lambein K; Department of Pathology, AZ St Lucas Hospital Gent, Gent, Belgium.
Libbrecht L; Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium.
Galant C; Department of Pathology, University Clinics St-Luc Brussels, Sint-Lambrechts-Woluwe, Belgium.
Van Bockstal MR; Department of Pathology, University Clinics St-Luc Brussels, Sint-Lambrechts-Woluwe, Belgium.

Histopathology ; 74(4): 666-668, 2019 03.

Article em En | MEDLINE | ID: mdl-30480328

Assuntos

Neoplasias da Mama/genética; Carcinoma Ductal de Mama/genética; Carcinoma Intraductal não Infiltrante/genética; Amplificação de Genes; Humanos; Receptor ErbB-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Ductal de Mama / Carcinoma Intraductal não Infiltrante Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google